G J Moore|J M Matsoukas - JoVE Visualize

Showing results (81-90 of 121) with videos related to

Pageof 13

Sort By:

Canadian Journal of Physiology and Pharmacology|July 1, 1992

Vascular actions of thrombin receptor peptideI Muramatsu, A Laniyonu, G J Moore, et al.

Journal of Medicinal Chemistry|September 1, 1979

Synthesis of angiotensin II antagonists containing sarcosine in position 7G J Moore, E M Oudeman, D Ko, et al.

Magnetic Resonance in Medicine|January 1, 1991

Analysis of diabetic cataractogenesis using chemical-shift nuclear magnetic resonance microscopyH M Cheng, J B Aguayo, G J Moore, et al.

Journal of Applied Toxicology : JAT|January 9, 2003

Discovery and design of novel inhibitors of botulinus neurotoxin A: targeted 'hinge' peptide librariesJ Hayden, J Pires, S Roy, et al.

Journal of the American Academy of Child and Adolescent Psychiatry|June 17, 1998

Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorderG J Moore, F P MacMaster, C Stewart, et al.

Molecular Pharmacology|June 1, 1993

Role of the amino- and carboxyl-terminal domains of thrombin receptor-derived polypeptides in biological activity in vascular endothelium and gastric smooth muscle: evidence for receptor subtypesM D Hollenberg, A A Laniyonu, M Saifeddine, et al.

Psychoneuroendocrinology|June 19, 2001

Prefrontal cortex as the site of estrogen's effect on cognitionP A Keenan, W H Ezzat, K Ginsburg, et al.

Journal of Child Neurology|September 29, 2001

Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imagingD R Rosenberg, A Amponsah, A Sullivan, et al.

Brain Research|February 9, 1981

An arginine vasotocin-like neuropeptide is present in the nervous system of the marine mollusc Aplysia californicaG J Moore, J A Thornhill, V Gill, et al.

International Journal of Peptide and Protein Research|July 1, 1991

Importance of the N-terminal domain of the type I angiotension II antagonist [Sar1,Ile8]ANG II for receptor blockadeG J Moore, R C Ganter, M H Goghari, et al.

Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:

Pageof 13

Canadian Journal of Physiology and Pharmacology|July 1, 1992

Vascular actions of thrombin receptor peptideI Muramatsu, A Laniyonu, G J Moore, et al.

Journal of Medicinal Chemistry|September 1, 1979

Synthesis of angiotensin II antagonists containing sarcosine in position 7G J Moore, E M Oudeman, D Ko, et al.

Magnetic Resonance in Medicine|January 1, 1991

Analysis of diabetic cataractogenesis using chemical-shift nuclear magnetic resonance microscopyH M Cheng, J B Aguayo, G J Moore, et al.

Journal of Applied Toxicology : JAT|January 9, 2003

Discovery and design of novel inhibitors of botulinus neurotoxin A: targeted 'hinge' peptide librariesJ Hayden, J Pires, S Roy, et al.

Journal of the American Academy of Child and Adolescent Psychiatry|June 17, 1998

Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorderG J Moore, F P MacMaster, C Stewart, et al.

Molecular Pharmacology|June 1, 1993

Role of the amino- and carboxyl-terminal domains of thrombin receptor-derived polypeptides in biological activity in vascular endothelium and gastric smooth muscle: evidence for receptor subtypesM D Hollenberg, A A Laniyonu, M Saifeddine, et al.

Psychoneuroendocrinology|June 19, 2001

Prefrontal cortex as the site of estrogen's effect on cognitionP A Keenan, W H Ezzat, K Ginsburg, et al.

Journal of Child Neurology|September 29, 2001

Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imagingD R Rosenberg, A Amponsah, A Sullivan, et al.

Brain Research|February 9, 1981

An arginine vasotocin-like neuropeptide is present in the nervous system of the marine mollusc Aplysia californicaG J Moore, J A Thornhill, V Gill, et al.

International Journal of Peptide and Protein Research|July 1, 1991

Importance of the N-terminal domain of the type I angiotension II antagonist [Sar1,Ile8]ANG II for receptor blockadeG J Moore, R C Ganter, M H Goghari, et al.

Pageof 13